1. |
Sakin A, Sahin S, Yasar N, et al. Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy. Lung Cancer, 2019, 133: 38-44.
|
2. |
Arenberg D. Update on screening for lung cancer. Transl Lung Cancer Res, 2019, 8(Suppl 1): S77-S87.77-87.
|
3. |
Morgensztern D, Ng SH, Gao F, et al. Trends in stage distribution for patients with non-small cell lung cancer: a national cancer database survey. J Thorac Oncol, 2010, 5(1): 29-33.
|
4. |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, Jan-Feb 2012, 62(1): 10-29.
|
5. |
Beale E, Zhu J, Chan L, et al. Blood transfusion in critically injured patients: a prospective study. Injury, 2006, 37(5): 455-465.
|
6. |
Cata JP, Wang H, Gottumukkala V, et al. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth, 2013, 110(5): 690-701.
|
7. |
Zuck TF, Thomson RA, Schreiber GB, et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion, Nov-Dec 1995, 35(11): 944-951.
|
8. |
Opelz G, Sengar DP, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc, 1973, 5(1): 253-259.
|
9. |
Opelz G, Vanrenterghem Y, Kirste G, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation, 1997, 63(7): 964-967.
|
10. |
Funaki S, Sawabata N, Nakagiri T, et al. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications. Eur J Cardiothorac Surg, 2011, 40(2): 322-327.
|
11. |
Brunsvig PF, Flatmark K, Aamdal S, et al. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients. Lung Cancer, 2008, 61(2): 170-176.
|
12. |
Sawabata N, Ohta M, Matsumura A, et al. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg, 2004, 77(2): 415-420.
|
13. |
Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg, 1984, 88(5 Pt 1): 659-662.
|
14. |
Little AG, Wu HS, Ferguson MK, et al. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg, 1990, 160(6): 630-632.
|
15. |
Nosotti M, Rebulla P, Riccardi D, et al. Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Chest, 2003, 124(1): 102-107.
|
16. |
Panagopoulos ND, Karakantza M, Koletsis E, et al. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer. Lung Cancer, 2008, 62(2): 273-280.
|
17. |
Cata JP, Chukka V, Wang H, et al. Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study. BMC Anesthesiol, 2013, 13(1): 42.
|
18. |
Cata JP, Gutierrez C, Mehran RJ, et al. Preoperative anemia, blood transfusion, and neutrophil-to-lymphocyte ratio in patients with stage Ⅰ non-small cell lung cancer. Cancer Cell Microenviron, 2016, 3(1): e1116.
|
19. |
Ng T, Ryder BA, Chern H, et al. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J Thorac Cardiovasc Surg, 2012, 143(4): 815-819.
|
20. |
Thomas P, Michelet P, Barlesi F, et al. Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies. Eur Respir J, 2007, 29(3): 565-570.
|
21. |
Moores DW, Piantadosi S, McKneally MF. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg, 1989, 47(3): 346-351.
|
22. |
陈敬华, 焦顺昌. 280 例非小细胞肺癌患者围手术期输血与否的预后关系. 中国肿瘤临床, 2007, 34(11): 632-935.
|
23. |
Pastorino U, Valente M, Cataldo I, et al. Perioperative blood transfusion and prognosis of resected stage Ⅰa lung cancer. Eur J Cancer Clin Oncol, 1986, 22(11): 1375-1378.
|
24. |
Keller SM, Groshen S, Martini N, et al. Blood transfusion and lung cancer recurrence. Cancer, 1988, 62(3): 606-610.
|
25. |
Rzyman W, Dziadziuszko R, Skokowski J, et al. The influence of blood transfusion on survival in operated non-small cell lung cancer patients. J Thorac Cardiovasc Surg, 2003, 126(3): 755-760.
|
26. |
Peñalver JC, Padilla J, Jordá C, et al. Use of blood products in patients treated surgically for stage I non-small cell lung cancer. Arch Bronconeumol, 2005, 41(9): 484-488.
|
27. |
Ghosh S, Ahmed K, Hopkinson DN, et al. Pulmonary adenocarcinoma is associated with poor long-term survival after surgical resection. Effect of allogeneic blood transfusion. Cancer, 2004, 101(9): 2058-2066.
|
28. |
Wu XL, Tu Q, Faure G, et al. Diagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Sci Rep, 2016, 6: 20210.
|
29. |
Rosenberg SA, Seipp CA, White DE, et al. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol, 1985, 3(5): 698-709.
|
30. |
Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg, 1992, 216(6): 633-638.
|
31. |
Asahara T, Katayama K, Itamoto T, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg, 1999, 23(7): 676-680.
|
32. |
Sun C, Wang Y, Yao HS, et al. Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int J Surg, 2015, 13: 102-110.
|
33. |
Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood, 1994, 84(6): 1703-1721.
|
34. |
van de Watering LM, Brand A, Houbiers JG, et al. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg, 2001, 88(2): 267-272.
|
35. |
Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest, Jan-Feb 1995, 24(1-2): 311-317.
|
36. |
Tomita M, Shimizu T, Hara M, et al. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients. Anticancer Res, May-Jun 2008, 28(3B): 1947-1950.
|
37. |
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 1995, 60(3): 615-622.
|
38. |
Latif MJ, Tan KS, Molena D, et al. Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg, 2019, 157(6): 2469-2477.
|
39. |
Churchhouse AM, Mathews TJ, McBride OM, et al. Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer? Interact Cardiovasc Thorac Surg, 2012, 14(1): 85-90.
|